Cite
Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority study.
MLA
Bjerum, Catherine M., et al. “Safety and Tolerability of Moxidectin and Ivermectin Combination Treatments for Lymphatic Filariasis in Côte d’Ivoire: A Randomized Controlled Superiority Study.” PLoS Neglected Tropical Diseases, vol. 17, no. 9, Sept. 2023, pp. 1–12. EBSCOhost, https://doi.org/10.1371/journal.pntd.0011633.
APA
Bjerum, C. M., Koudou, B. G., Ouattara, A. F., Lew, D., Goss, C. W., Gabo, P. T., King, C. L., Fischer, P. U., Weil, G. J., & Budge, P. J. (2023). Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d’Ivoire: A randomized controlled superiority study. PLoS Neglected Tropical Diseases, 17(9), 1–12. https://doi.org/10.1371/journal.pntd.0011633
Chicago
Bjerum, Catherine M., Benjamin G. Koudou, Allassane F. Ouattara, Daphne Lew, Charles W. Goss, Pascal T. Gabo, Christopher L. King, Peter U. Fischer, Gary J. Weil, and Philip J. Budge. 2023. “Safety and Tolerability of Moxidectin and Ivermectin Combination Treatments for Lymphatic Filariasis in Côte d’Ivoire: A Randomized Controlled Superiority Study.” PLoS Neglected Tropical Diseases 17 (9): 1–12. doi:10.1371/journal.pntd.0011633.